Skip to content
Pharma Observatory a Scientist.com platform

Organization (Academic)

Wonkwang University

ClinicalTrials.gov lists Wonkwang University as lead sponsor of 27 trials, counting the companies grouped under it.

KR Academic
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

2 0 2006 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Wonkwang University and 1 company grouped under it: 27 lead-sponsored trials (1 its own, 26 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).

Get the Wonkwang University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
Wonkwang University Hospital 26 1

Disease areas (48)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 5
Coronary Artery Disease 3
Coronary Disease 3
Inflammatory Bowel Diseases 3
Stroke 3

Trials by start year as sponsor or collaborator (12)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2019 1
2018 2
2017 1
2016 1
2015 1
2014 1
2013 1
2012 2
2011 1
2010 1

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Journals published in (76)

Shown in this order: most published in first.

Journals published in
Journal Publications
Gastrointestinal endoscopy 4
Anesthesia and analgesia 2
Anesthesia and pain medicine 2
Archives of physical medicine and rehabilitation 2
BMJ open 2

Organization relationships (49)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Yonsei University Co sponsors trial with 7
Seoul National University Co sponsors trial with 7
Korea University Co sponsors trial with 4
Samsung (South Korea) Co sponsors trial with 4
Ewha Womans University Co sponsors trial with 4

Latest dated events (52)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-07-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
FBRS Trial collaborator Named in trial exclusion criteria
FBXO8 Trial collaborator Named in trial exclusion criteria
GGT1 Trial collaborator Named in trial exclusion criteria
FBRS Trial collaborator Mentioned in trial text
FBXO8 Trial collaborator Mentioned in trial text

Biomarkers this organization publishes on (99)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CRP 6
P2RY12 6
CYP2C19 4
FAS 4
GAST 4

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.